These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1676911)

  • 21. Genomic HLA-typing by RFLP-analysis using DR beta and DQ beta cDNA probes reveals normal DR-DQ linkages in patients with psoriasis vulgaris.
    Olerup O; Wallin J; Carlsson B; Marcusson J; Emtestam L; Björnelius E; Möller E
    Tissue Antigens; 1987 Sep; 30(3):139-42. PubMed ID: 2892283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-DR-DQ haplotypes defined by restriction fragment analysis. Correlation to serology.
    Carlsson B; Wallin J; Böhme J; Möller E
    Hum Immunol; 1987 Oct; 20(2):95-113. PubMed ID: 2890607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-DR typing using restriction fragment length polymorphism (RFLP) with one enzyme and two probes.
    Riisom K; Søorensen IJ; Møoller B; Kruse TA; Graugaard B; Lamm LU
    Tissue Antigens; 1988 Mar; 31(3):141-50. PubMed ID: 2897728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RFLP of the HLA-DQ alpha region: a diallelic DX alpha polymorphism, not linked to DR and DQ specificities.
    Tilanus MG; Van Eggermond MC; Fei H; D'Amaro J; Schreuder GM; Giphart MJ
    Tissue Antigens; 1987 Sep; 30(3):128-34. PubMed ID: 2892281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A method for HLA-DQA typing by the PCR-SSP technique.
    Forssmann U; Mytilineos J; Scherer S; Opelz G
    Transpl Int; 1994; 7 Suppl 1():S515-8. PubMed ID: 11271295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
    Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
    J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA class II gene frequencies in Italy.
    Amoroso A; Mazzola G; Berrino M; Canale L; Borelli I; Dall'Omo AM; Tacconella M; Fasano ME; Praticò L; Piana L
    Gene Geogr; 1991; 5(1-2):75-86. PubMed ID: 1726464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complete analysis of HLA-DQB1 polymorphism and DR-DQ linkage disequilibrium by oligonucleotide typing.
    Morel C; Zwahlen F; Jeannet M; Mach B; Tiercy JM
    Hum Immunol; 1990 Sep; 29(1):64-77. PubMed ID: 1976613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes.
    Mangklabruks A; Cox N; DeGroot LJ
    J Clin Endocrinol Metab; 1991 Aug; 73(2):236-44. PubMed ID: 1677360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Report from the HLA class II typing by PCR-SSP Multicentre Study.
    Zetterquist H; Bengtsson M; Bäckström G; Egle-Jansson I; Ekdahl AM; Grunnet N; Gustafsson I; Knutsen I; Kuhle A; Rydberg L; Spurkland A; Steffensen R; Storgärds M; Szojmer E; Söderholm G; Thuresson B; Turesson H; Olerup O
    Eur J Immunogenet; 1997 Jun; 24(3):191-199. PubMed ID: 9226125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategy for definition of DR/DQ haplotypes in the 4AOHW cell panel using noncoding sequence polymorphisms.
    Simons MJ; Limm TM; Naughton MJ; Quinn DL; McGinnis MD; Ashdown ML
    Hum Immunol; 1993 Sep; 38(1):69-74. PubMed ID: 7905871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Segregation of HLA-DR, -DQ and -DP phenotypes and restriction fragment length polymorphic fragments in two recombinant families.
    Munck Petersen C; Juncker Sørensen I; Hyldig-Nielsen JJ; Lamm LU
    Tissue Antigens; 1988 Aug; 32(2):104-11. PubMed ID: 2904184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of polymorphic HLA-DR and -DQ alleles as determined by restriction fragment length polymorphism analysis in an Austrian population.
    Fischer GF; Faé I; Pickl WF
    Vox Sang; 1992; 62(4):236-41. PubMed ID: 1353645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA-RFLP analysis and genotyping of HLA-DR and DQ antigens.
    Bidwell J
    Immunol Today; 1988 Jan; 9(1):18-23. PubMed ID: 2908266
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies of restriction fragment length polymorphism (RFLP) of DR and DQ genes in HLA-DR3 positive patients with Graves' disease or systemic lupus erythematosus.
    Garcia-Ameijeiras A; Gladman DD; Chan JY; Volpé R
    Clin Invest Med; 1993 Oct; 16(5):326-32. PubMed ID: 7903231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Definition of DRw10 specificity by restriction fragment length polymorphism.
    Semana G; Bignon JD; Quillivic F; Cheneau ML; Herniou E; Muller JY; Genetet B; Fauchet R
    Tissue Antigens; 1988 Sep; 32(3):113-20. PubMed ID: 2464202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA class II genes: typing by DNA analysis.
    Bidwell JL; Bidwell EA; Bradley BA
    Baillieres Clin Haematol; 1990 Apr; 3(2):355-84. PubMed ID: 1977481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High resolution HLA-DQB1 typing by combination of PCR-RFLP and PCR-SSCP.
    Park MH; Whang DH; Kang SJ
    Hum Immunol; 1999 Sep; 60(9):901-7. PubMed ID: 10527400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of RFLP-DR beta and serological HLA-DR typing in 1500 individuals.
    Mytilineos J; Scherer S; Opelz G
    Transplantation; 1990 Nov; 50(5):870-3. PubMed ID: 1978425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DR typing of renal allograft patients and donors by DNA-RFLP: correlation with pretransplant serotyping.
    Wood N; Joysey V; Bidwell J; Klouda P
    Transplant Proc; 1990 Oct; 22(5):2287. PubMed ID: 1977225
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.